FTC investigates Teva over contested product patents [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.tevapharm.com
Company Research
Source: Yahoo! Finance
Trade Commission (FTC) has opened an investigation into Teva Pharmaceuticals. The federal agency is probing certain patents that may have blocked competition for asthma and chronic obstructive pulmonary disease (COPD) medications. Last week, on the basis that Teva has wrongly made “minor tweaks” to its products in a bid to keep patent exclusivity, the FTC sent a civil investigative demand ordering the company to provide internal communications, analysis and financial data related to the contested patents, The Washington Post first reported. The patents were listed in the US Food and Drug Administration's (FDA) Orange Book, which is formally known as a compendium for the “Approved Drug Products with Therapeutic Equivalence Evaluations.” The Orange Book includes a list of safe and effective drug products that have been approved by the FDA. As per the report, Teva has until 24 July to comply with the FTC's order. The FTC first waded into the dispute in April when the commission s
Show less
Read more
Impact Snapshot
Event Time:
TEVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TEVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TEVA alerts
High impacting Teva Pharmaceutical Industries Limited American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TEVA
News
- Global Herpes Treatment Market Size To Worth USD 1.87 Billion By 2033 | CAGR Of 4.28% [Yahoo! Finance]Yahoo! Finance
- Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 2024Business Wire
- EAN 2024: Treatment cessation and reinitiation can reduce benefits of Ajovy [Yahoo! Finance]Yahoo! Finance
- Real-World Evidence and Life Science Analytics 2 Day Conference (Boston, USA - October 17th-18th 2024) - Shaping the Future of Healthcare [Yahoo! Finance]Yahoo! Finance
- Medincell to Present Data Showing Enhanced Potential of Tumor-Targeting Monoclonal Antibody in Melanoma Using BEPO® Technology [Yahoo! Finance]Yahoo! Finance
TEVA
Earnings
- 5/8/24 - Miss
TEVA
Sec Filings
- 6/25/24 - Form 8-K
- 6/21/24 - Form 4
- 6/18/24 - Form 144
- TEVA's page on the SEC website